BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35628310)

  • 1. Impaired LEF1 Activation Accelerates iPSC-Derived Keratinocytes Differentiation in Hutchinson-Gilford Progeria Syndrome.
    Mao X; Xiong ZM; Xue H; Brown MA; Gete YG; Yu R; Sun L; Cao K
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysfunction of iPSC-derived endothelial cells in human Hutchinson-Gilford progeria syndrome.
    Matrone G; Thandavarayan RA; Walther BK; Meng S; Mojiri A; Cooke JP
    Cell Cycle; 2019 Oct; 18(19):2495-2508. PubMed ID: 31411525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of mitochondrial dysfunction in Hutchinson-Gilford progeria syndrome through use of stable isotope labeling with amino acids in cell culture.
    Rivera-Torres J; Acín-Perez R; Cabezas-Sánchez P; Osorio FG; Gonzalez-Gómez C; Megias D; Cámara C; López-Otín C; Enríquez JA; Luque-García JL; Andrés V
    J Proteomics; 2013 Oct; 91():466-77. PubMed ID: 23969228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
    Finley J
    Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diminished Canonical β-Catenin Signaling During Osteoblast Differentiation Contributes to Osteopenia in Progeria.
    Choi JY; Lai JK; Xiong ZM; Ren M; Moorer MC; Stains JP; Cao K
    J Bone Miner Res; 2018 Nov; 33(11):2059-2070. PubMed ID: 30001457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recapitulation of premature ageing with iPSCs from Hutchinson-Gilford progeria syndrome.
    Liu GH; Barkho BZ; Ruiz S; Diep D; Qu J; Yang SL; Panopoulos AD; Suzuki K; Kurian L; Walsh C; Thompson J; Boue S; Fung HL; Sancho-Martinez I; Zhang K; Yates J; Izpisua Belmonte JC
    Nature; 2011 Apr; 472(7342):221-5. PubMed ID: 21346760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of angiogenic incompetence in Hutchinson-Gilford progeria via downregulation of endothelial NOS.
    Gete YG; Koblan LW; Mao X; Trappio M; Mahadik B; Fisher JP; Liu DR; Cao K
    Aging Cell; 2021 Jul; 20(7):e13388. PubMed ID: 34086398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal expression of the truncated prelamin A causing Hutchinson-Gilford progeria syndrome: effects on keratinocytes, hair and skin.
    Wang Y; Panteleyev AA; Owens DM; Djabali K; Stewart CL; Worman HJ
    Hum Mol Genet; 2008 Aug; 17(15):2357-69. PubMed ID: 18442998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reprogramming progeria fibroblasts re-establishes a normal epigenetic landscape.
    Chen Z; Chang WY; Etheridge A; Strickfaden H; Jin Z; Palidwor G; Cho JH; Wang K; Kwon SY; Doré C; Raymond A; Hotta A; Ellis J; Kandel RA; Dilworth FJ; Perkins TJ; Hendzel MJ; Galas DJ; Stanford WL
    Aging Cell; 2017 Aug; 16(4):870-887. PubMed ID: 28597562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Tissue Engineered Blood Vessel Model of Hutchinson-Gilford Progeria Syndrome Using Human iPSC-derived Smooth Muscle Cells.
    Atchison L; Zhang H; Cao K; Truskey GA
    Sci Rep; 2017 Aug; 7(1):8168. PubMed ID: 28811655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hutchinson-Gilford progeria patient-derived cardiomyocyte model of carrying LMNA gene variant c.1824 C > T.
    Perales S; Sigamani V; Rajasingh S; Czirok A; Rajasingh J
    Cell Tissue Res; 2023 Oct; 394(1):189-207. PubMed ID: 37572165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
    Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
    Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transient expression of an adenine base editor corrects the Hutchinson-Gilford progeria syndrome mutation and improves the skin phenotype in mice.
    Whisenant D; Lim K; Revêchon G; Yao H; Bergo MO; Machtel P; Kim JS; Eriksson M
    Nat Commun; 2022 Jun; 13(1):3068. PubMed ID: 35654881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): Current trends and future perspectives for drug discovery.
    Lo Cicero A; Nissan X
    Ageing Res Rev; 2015 Nov; 24(Pt B):343-8. PubMed ID: 26474742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice.
    Koblan LW; Erdos MR; Wilson C; Cabral WA; Levy JM; Xiong ZM; Tavarez UL; Davison LM; Gete YG; Mao X; Newby GA; Doherty SP; Narisu N; Sheng Q; Krilow C; Lin CY; Gordon LB; Cao K; Collins FS; Brown JD; Liu DR
    Nature; 2021 Jan; 589(7843):608-614. PubMed ID: 33408413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
    Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
    Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic involvement in Hutchinson-Gilford progeria syndrome: a mini-review.
    Arancio W; Pizzolanti G; Genovese SI; Pitrone M; Giordano C
    Gerontology; 2014; 60(3):197-203. PubMed ID: 24603298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hutchinson-Gilford progeria syndrome through the lens of transcription.
    Prokocimer M; Barkan R; Gruenbaum Y
    Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impairment of nuclear F-actin formation and its relevance to cellular phenotypes in Hutchinson-Gilford progeria syndrome.
    Takahashi Y; Hiratsuka S; Machida N; Takahashi D; Matsushita J; Hozak P; Misteli T; Miyamoto K; Harata M
    Nucleus; 2020 Dec; 11(1):250-263. PubMed ID: 32954953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hutchinson-Gilford Progeria Syndrome (Hgps) and Application of Gene Therapy Based Crispr/Cas Technology as A Promising Innovative Treatment Approach.
    Rajeev M; Ratan C; Krishnan K; Vijayan M
    Recent Pat Biotechnol; 2021; 15(4):266-285. PubMed ID: 34602042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.